{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T07:02:12Z","timestamp":1780038132249,"version":"3.53.1"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Current injectable vaccines targeting respiratory viruses are highly effective in inducing systemic immunity, yet they fall short in establishing effective defenses at mucosal sites, ultimately failing to completely block viral infection and transmission. Developing novel immune strategies that can simultaneously activate mucosal and systemic immunity is vitally important.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this study, we created a pulmonary mucosal immune nanovaccine platform based on dimethyldioctadecyl ammonium (DDA) cationic liposomes. The immune effect was systematically evaluated using\n                      <jats:italic>in vitro<\/jats:italic>\n                      dendritic cell activation tests and a mouse pulmonary mucosal immune model.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The results showed that the prepared formulation had a uniform particle size (approximately 101 nm), positive zeta potential (+42.67 mV), and high encapsulation efficiency (over 80%). The formulation effectively stimulated the maturation of dendritic cells, induced high levels of antigen-specific IgG antibodies in serum and IgA antibodies in bronchoalveolar lavage fluid. It also significantly promoted the proliferation of activated T\/B cells and the formation of tissue-resident memory T cells in lung tissues. Mechanistic studies revealed that the vaccine was retained in the lung for a long time and was subsequently detected in mediastinal lymph nodes, accompanied by increased activation-associated dendritic-cell phenotypes, thereby synergistically activating mucosal and systemic immune responses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>\n                      Overall, this study provides preliminary proof-of-concept evidence that the DDA liposome-based formulation has immunogenic potential following pulmonary mucosal administration. However, additional\n                      <jats:italic>in vivo<\/jats:italic>\n                      control groups and more rigorous validation of antigen-specific immune responses will be required in future studies.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1824741","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T06:09:01Z","timestamp":1780034941000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Preliminary evaluation of a DDA cationic liposome-based pulmonary mucosal immunization platform carrying a SARS-CoV-2 spike-derived branched peptide"],"prefix":"10.3389","volume":"17","author":[{"given":"Zhifa","family":"Xia","sequence":"first","affiliation":[{"name":"Medical School of Chinese People\u2019s Liberation Army General Hospital","place":["Beijing, China"]},{"name":"Pharmaceutical Sciences Research Division, Department of Pharmacy, Medical Supplies Center, Chinese People\u2019s Liberation Army General Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyong","family":"Yang","sequence":"additional","affiliation":[{"name":"Medical School of Chinese People\u2019s Liberation Army General Hospital","place":["Beijing, China"]},{"name":"Pharmaceutical Sciences Research Division, Department of Pharmacy, Medical Supplies Center, Chinese People\u2019s Liberation Army General Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenwei","family":"Shi","sequence":"additional","affiliation":[{"name":"Medical School of Chinese People\u2019s Liberation Army General Hospital","place":["Beijing, China"]},{"name":"Pharmaceutical Sciences Research Division, Department of Pharmacy, Medical Supplies Center, Chinese People\u2019s Liberation Army General Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songtao","family":"Huang","sequence":"additional","affiliation":[{"name":"Medical School of Chinese People\u2019s Liberation Army General Hospital","place":["Beijing, China"]},{"name":"Pharmaceutical Sciences Research Division, Department of Pharmacy, Medical Supplies Center, Chinese People\u2019s Liberation Army General Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghua","family":"Xu","sequence":"additional","affiliation":[{"name":"Pharmaceutical Sciences Research Division, Department of Pharmacy, Medical Supplies Center, Chinese People\u2019s Liberation Army General Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2550-z","article-title":"SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls","volume":"584","author":"Le Bert","year":"2020","journal-title":"Nature"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.103841","article-title":"Intranasal COVID-19 vaccines: From bench to bed","volume":"76","author":"Alu","year":"2022","journal-title":"EBioMedicine"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12020191","article-title":"Vaccine strategies to elicit mucosal immunity","volume":"12","author":"Song","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104585","article-title":"Mucosal vaccines for SARS-CoV-2: triumph of hope over experience","volume":"92","author":"Pilapitiya","year":"2023","journal-title":"EBioMedicine"},{"key":"B5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nri.2015.3","article-title":"Tissue-resident memory T cells: local specialists in immune defence","volume":"16","author":"Mueller","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.0105-2896.2005.00299.x","article-title":"Bronchus- and nasal-associated lymphoid tissues","volume":"206","author":"Bienenstock","year":"2005","journal-title":"Immunol Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-10-97","article-title":"Expression of endothelia and lymphocyte adhesion molecules in bronchus-associated lymphoid tissue (BALT) in adult human lung","volume":"10","author":"Kawamata","year":"2009","journal-title":"Respir Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1419527","article-title":"Harnessing the potential of the NALT and BALT as targets for immunomodulation using engineering strategies to enhance mucosal uptake","volume":"15","author":"Seefeld","year":"2024","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1433452","article-title":"Mucosal immunity in COVID-19: a comprehensive review","volume":"15","author":"Alqahtani","year":"2024","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11040849","article-title":"SARS-CoV-2: Immunity, challenges with current vaccines, and a novel perspective on mucosal vaccines","volume":"11","author":"Sunagar","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.7774\/cevr.2022.11.3.235","article-title":"Development of mucosal vaccine delivery: an overview on the mucosal vaccines and their adjuvants","volume":"11","author":"Anggraeni","year":"2022","journal-title":"Clin Exp Vaccine Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11020305","article-title":"The development of surface-modified liposomes as an intranasal delivery system for group A Streptococcus vaccines","volume":"11","author":"Yang","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11091035","article-title":"Intranasal immunization with liposome-displayed receptor-binding domain induces mucosal immunity and protection against SARS-CoV-2","volume":"11","author":"Huang","year":"2022","journal-title":"Pathogens"},{"key":"B14","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1208\/s12249-022-02425-3","article-title":"Enhanced influenza immunity by nasal mucosal administration of the TPGS-modified liposomal vaccine","volume":"23","author":"Ma","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1080\/21691401.2018.1438450","article-title":"Cationic DDA\/TDB liposome as a mucosal vaccine adjuvant for uptake by dendritic cells in vitro induces potent humoural immunity","volume":"46","author":"Qu","year":"2018","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2016.04.012","article-title":"Liposome-based intranasal delivery of lipopeptide vaccine candidates against group A streptococcus","volume":"41","author":"Ghaffar","year":"2016","journal-title":"Acta Biomater"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics8010007","article-title":"Liposome-based adjuvants for subunit vaccines: formulation strategies for subunit antigens and immunostimulators","volume":"8","author":"Tandrup Schmidt","year":"2016","journal-title":"Pharmaceutics"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2022.01.009","article-title":"Elucidating inhaled liposome surface charge on its interaction with biological barriers in the lung","volume":"172","author":"Zhao","year":"2022","journal-title":"Eur J Pharm Biopharm"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1586\/erv.11.17","article-title":"Cationic liposomes as vaccine adjuvants","volume":"10","author":"Christensen","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1039\/c1nr10166h","article-title":"The role of surface charge density in cationic liposome-promoted dendritic cell maturation and vaccine-induced immune responses","volume":"3","author":"Ma","year":"2011","journal-title":"Nanoscale"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.9b00730","article-title":"Scale-independent microfluidic production of cationic liposomal adjuvants and development of enhanced lymphatic targeting strategies","volume":"16","author":"Roces","year":"2019","journal-title":"Mol Pharm"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2009.10.022","article-title":"Liposomes based on dimethyldioctadecylammonium promote a depot effect and enhance immunogenicity of soluble antigen","volume":"142","author":"Henriksen-Lacey","year":"2010","journal-title":"J Control Release"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid nanoparticles\u2500From liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.145228","article-title":"Intranasal immunization with peptide-based immunogenic complex enhances BCG vaccine efficacy in a murine model of tuberculosis","volume":"6","author":"Kumar","year":"2021","journal-title":"JCI Insight"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1021\/mp100208f","article-title":"Comparison of the depot effect and immunogenicity of liposomes based on dimethyldioctadecylammonium (DDA), 3\u03b2-[N-(N\u2019,N\u2019-Dimethylaminoethane)carbomyl] cholesterol (DC-Chol), and 1,2-dioleoyl-3-trimethylammonium propane (DOTAP): prolonged liposome retention mediates stronger Th1 responses","volume":"8","author":"Henriksen-Lacey","year":"2011","journal-title":"Mol Pharm"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2905196","article-title":"Exploring the S protein of SARS-CoV-2 to design a novel multi-epitope vaccine against COVID-19 based on immunoinformatics approaches","volume":"29","author":"Huang","year":"2024","journal-title":"Front Biosci (Landmark Ed)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2013.01.064","article-title":"Nanoparticle diffusion in respiratory mucus from humans without lung disease","volume":"34","author":"Schuster","year":"2013","journal-title":"Biomaterials"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3109\/1061186X.2015.1086359","article-title":"Size selectivity of intestinal mucus to diffusing particulates is dependent on surface chemistry and exposure to lipids","volume":"23","author":"Yildiz","year":"2015","journal-title":"J Drug Target"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2018.01.018","article-title":"Self-emulsifying peptide drug delivery systems: How to make them highly mucus permeating","volume":"538","author":"Griesser","year":"2018","journal-title":"Int J Pharm"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01043","article-title":"Peptide vaccines for leishmaniasis","volume":"9","author":"De Brito","year":"2018","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S359118","article-title":"The mucoadhesive nanoparticle-based delivery system in the development of mucosal vaccines","volume":"17","author":"Zhao","year":"2022","journal-title":"Int J Nanomedicine"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.9.5210-5218.2003","article-title":"Liposomal meningococcal B vaccination: role of dendritic cell targeting in the development of a protective immune response","volume":"71","author":"Arigita","year":"2003","journal-title":"Infect Immun"},{"key":"B33","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.jconrel.2023.03.006","article-title":"A liposomal vaccine promotes strong adaptive immune responses via dendritic cell activation in draining lymph nodes","volume":"356","author":"Agallou","year":"2023","journal-title":"J Control Release"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1021\/acs.nanolett.9b00030","article-title":"Targeted codelivery of an antigen and dual agonists by hybrid nanoparticles for enhanced cancer immunotherapy","volume":"19","author":"Zhang","year":"2019","journal-title":"Nano Lett"},{"key":"B35","doi-asserted-by":"publisher","first-page":"10801","DOI":"10.1038\/s41467-024-55083-3","article-title":"Cytokine-armed pyroptosis induces antitumor immunity against diverse types of tumors","volume":"15","author":"Orehek","year":"2024","journal-title":"Nat Commun"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.575597","article-title":"Localized interleukin-12 for cancer immunotherapy","volume":"11","author":"Nguyen","year":"2020","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202318632","article-title":"NIR-II conjugated electrolytes as biomimetics of lipid bilayers for in vivo liposome tracking","volume":"63","author":"Meng","year":"2024","journal-title":"Angew Chem Int Ed Engl"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.769088","article-title":"Epigallocatechin-3-gallate as a novel vaccine adjuvant","volume":"12","author":"Cheong","year":"2021","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2007.08.014","article-title":"Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance","volume":"27","author":"Cao","year":"2007","journal-title":"Immunity"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.04.005","article-title":"Regulatory B cells: origin, phenotype, and function","volume":"42","author":"Rosser","year":"2015","journal-title":"Immunity"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1824741\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T06:09:02Z","timestamp":1780034942000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1824741\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":40,"alternative-id":["10.3389\/fimmu.2026.1824741"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1824741","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"article-number":"1824741"}}